Alpha Teknova (TKNO) Asset Writedowns and Impairment (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Asset Writedowns and Impairment came in at $7000.0 in Q1 2026, down 98.4% year-on-year from $437000.0 in Q1 2025, and down 98.47% on a QoQ basis from $458000.0 in Q4 2025.
Alpha Teknova (TKNO) Asset Writedowns and Impairment (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Asset Writedowns and Impairment data on file, last reported at $7000.0 in Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 98.4% year-over-year to $7000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 233.0% increase from a year earlier, with the FY2025 full-year figure at $2.1 million, up 1526.92% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $7000.0, down from $458000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for TKNO reached as high as $2.2 million in Q2 2023 and fell as low as -$109000.0 in Q4 2023.
- Historically, Asset Writedowns and Impairment has averaged $412500.0 across 5 years, with a median of $253000.0 in 2024.
- Across the five-year window, Asset Writedowns and Impairment slumped 116.44% in 2023 and soared 6142.86% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $663000.0 in 2022, then slumped by 116.44% to -$109000.0 in 2023, then jumped by 163.3% to $69000.0 in 2024, then surged by 563.77% to $458000.0 in 2025, then sank by 98.47% to $7000.0 in 2026.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $7000.0 in Q1 2026, $458000.0 in Q4 2025, and $732000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,000.00 |
| Mar 31, 2026 | 7,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Dec 31, 2025 | 458,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Sep 30, 2025 | 732,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Jun 30, 2025 | 488,000.00 |
| Mar 31, 2025 | 437,000.00 |
| Mar 31, 2025 | 437,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | -109,000.00 |
| Dec 31, 2023 | -109,000.00 |
| Jun 30, 2023 | 2.20 Mn |
| Jun 30, 2023 | 2.20 Mn |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |